Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Mitamura

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 28, 2019
Clinical evaluation of ID NOW influenza A & B 2, a rapid influenza virus detection kit using isothermal nucleic acid amplification technology - A comparison with currently available testsKeiko Mitamura, Hideaki Shimizu, Masahiko Yamazaki, et al.
Epidemiology and Infection|January 23, 2024
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in JapanSeiya Yamayoshi, Etsuko Nagai, Keiko Mitamura, et al.
Scientific Reports|January 25, 2018
Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma pneumoniaeHo Namkoong, Masahiko Yamazaki, Masami Ishizaki, et al.
Viruses|March 26, 2022
A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVsDavid Pattinson, Peter Jester, Lizheng Guan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 24, 2019
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018Emi Takashita, Chiharu Kawakami, Hiroko Morita, et al.
Vaccine|August 11, 2018
Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 seasonMasayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 9, 2026
Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24Emi Takashita, Seiichiro Fujisaki, Hiroko Morita, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 28, 2019
Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019Emi Takashita, Chiharu Kawakami, Rie Ogawa, et al.
Emerging Infectious Diseases|August 23, 2019
Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019Emi Takashita, Masataka Ichikawa, Hiroko Morita, et al.
Nature|October 8, 2004
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virusDarwyn Kobasa, Ayato Takada, Kyoko Shinya, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 28, 2019
Clinical evaluation of ID NOW influenza A & B 2, a rapid influenza virus detection kit using isothermal nucleic acid amplification technology - A comparison with currently available testsKeiko Mitamura, Hideaki Shimizu, Masahiko Yamazaki, et al.
Epidemiology and Infection|January 23, 2024
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in JapanSeiya Yamayoshi, Etsuko Nagai, Keiko Mitamura, et al.
Scientific Reports|January 25, 2018
Clinical Evaluation of the Immunochromatographic System Using Silver Amplification for the Rapid Detection of Mycoplasma pneumoniaeHo Namkoong, Masahiko Yamazaki, Masami Ishizaki, et al.
Viruses|March 26, 2022
A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVsDavid Pattinson, Peter Jester, Lizheng Guan, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 24, 2019
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018Emi Takashita, Chiharu Kawakami, Hiroko Morita, et al.
Vaccine|August 11, 2018
Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 seasonMasayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 9, 2026
Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24Emi Takashita, Seiichiro Fujisaki, Hiroko Morita, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 28, 2019
Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019Emi Takashita, Chiharu Kawakami, Rie Ogawa, et al.
Emerging Infectious Diseases|August 23, 2019
Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019Emi Takashita, Masataka Ichikawa, Hiroko Morita, et al.
Nature|October 8, 2004
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virusDarwyn Kobasa, Ayato Takada, Kyoko Shinya, et al.
Pageof 6